201 related articles for article (PubMed ID: 27965305)
1. Bone Marrow Cell Trafficking Analyzed by
Asiedu KO; Koyasu S; Szajek LP; Choyke PL; Sato N
Clin Cancer Res; 2017 Jun; 23(11):2759-2768. PubMed ID: 27965305
[No Abstract] [Full Text] [Related]
2. Bone marrow cell homing to sites of acute tibial fracture:
Asiedu KO; Ferdousi M; Ton PT; Adler SS; Choyke PL; Sato N
EJNMMI Res; 2018 Dec; 8(1):109. PubMed ID: 30547233
[TBL] [Abstract][Full Text] [Related]
3. (89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies.
Sato N; Wu H; Asiedu KO; Szajek LP; Griffiths GL; Choyke PL
Radiology; 2015 May; 275(2):490-500. PubMed ID: 25706654
[TBL] [Abstract][Full Text] [Related]
4.
Sato N; Stringaris K; Davidson-Moncada JK; Reger R; Adler SS; Dunbar C; Choyke PL; Childs RW
Clin Cancer Res; 2020 Jun; 26(11):2573-2581. PubMed ID: 32034075
[TBL] [Abstract][Full Text] [Related]
5. Imaging of cell-based therapy using
Kurebayashi Y; Choyke PL; Sato N
Nanotheranostics; 2021; 5(1):27-35. PubMed ID: 33391973
[TBL] [Abstract][Full Text] [Related]
6. The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.
Girbl T; Lunzer V; Greil R; Namberger K; Hartmann TN
Transfusion; 2014 Sep; 54(9):2325-35. PubMed ID: 24673458
[TBL] [Abstract][Full Text] [Related]
7. PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with
Weist MR; Starr R; Aguilar B; Chea J; Miles JK; Poku E; Gerdts E; Yang X; Priceman SJ; Forman SJ; Colcher D; Brown CE; Shively JE
J Nucl Med; 2018 Oct; 59(10):1531-1537. PubMed ID: 29728514
[TBL] [Abstract][Full Text] [Related]
8. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.
Kollet O; Spiegel A; Peled A; Petit I; Byk T; Hershkoviz R; Guetta E; Barkai G; Nagler A; Lapidot T
Blood; 2001 May; 97(10):3283-91. PubMed ID: 11342460
[TBL] [Abstract][Full Text] [Related]
9. Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.
Goodrich AD; Varain NM; Jeanblanc CM; Colon DM; Kim J; Zanjani ED; Hematti P
Cytotherapy; 2014 Sep; 16(9):1280-93. PubMed ID: 25108653
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of 89Zr-oxine-labeled human bone marrow-derived mesenchymal stem cells by micro-PET/computed tomography imaging in Sprague-Dawley rats.
Wang S; Wang Y; Xu B; Qin T; Lv Y; Yan H; Shao Y; Fang Y; Zheng S; Qiu Y
Nucl Med Commun; 2022 Jul; 43(7):834-846. PubMed ID: 35438673
[TBL] [Abstract][Full Text] [Related]
11. [Effects of the mobilization with AMD3100, granulocyte-colony-stimulating factor (G-CSF) alone and in combination on the immunological function of the lymphocytes in mice].
Kong Y; Feng R; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):358-61. PubMed ID: 22781791
[TBL] [Abstract][Full Text] [Related]
12. Tracking of NK Cells by Positron Emission Tomography Using
Sato N; Szajek LP; Choyke PL
Methods Mol Biol; 2022; 2463():153-161. PubMed ID: 35344173
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of the Synthesis and Cell Labelling Conditions for [
Friberger I; Jussing E; Han J; Goos JACM; Siikanen J; Kaipe H; Lambert M; Harris RA; Samén E; Carlsten M; Holmin S; Tran TA
Mol Imaging Biol; 2021 Dec; 23(6):952-962. PubMed ID: 34231103
[TBL] [Abstract][Full Text] [Related]
14. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.
Hartmann T; Hübel K; Monsef I; Engert A; Skoetz N
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010615. PubMed ID: 26484982
[TBL] [Abstract][Full Text] [Related]
15. [A Single-Center Analysis of the Use of G-CSF Combined with Plerixafor to Mobilize Peripheral Blood Hematopoietic Stem Cell from Healthy Related Donors in Allogeneic Hematopoietic Stem Cell Transplantation].
Chen J; Yuan LL; Zhang X; Qiao JL; Yin QX; Zhang YM; Yang XL; Cao XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):286-291. PubMed ID: 35123641
[TBL] [Abstract][Full Text] [Related]
16. Mobilization as a preparative regimen for hematopoietic stem cell transplantation.
Chen J; Larochelle A; Fricker S; Bridger G; Dunbar CE; Abkowitz JL
Blood; 2006 May; 107(9):3764-71. PubMed ID: 16439683
[TBL] [Abstract][Full Text] [Related]
17. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.
Steinberg M; Silva M
Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow.
Devi S; Wang Y; Chew WK; Lima R; A-González N; Mattar CN; Chong SZ; Schlitzer A; Bakocevic N; Chew S; Keeble JL; Goh CC; Li JL; Evrard M; Malleret B; Larbi A; Renia L; Haniffa M; Tan SM; Chan JK; Balabanian K; Nagasawa T; Bachelerie F; Hidalgo A; Ginhoux F; Kubes P; Ng LG
J Exp Med; 2013 Oct; 210(11):2321-36. PubMed ID: 24081949
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony-stimulating factor in healthy haploidentical stem cell donors.
Kurnikova E; Trakhtman P; Balashov D; Garloeva J; Kumukova I; Khismatullina R; Pershin D; Shelikhova L; Novichkova G; Maschan A
Vox Sang; 2022 Jun; 117(6):853-861. PubMed ID: 35332550
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking.
Pluchino N; Mamillapalli R; Shaikh S; Habata S; Tal A; Gaye M; Taylor HS
J Cell Mol Med; 2020 Feb; 24(4):2464-2474. PubMed ID: 31904910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
